Operation Warp Speed and the COVID-19 Vaccine

Name: Operation Warp Speed and the COVID-19 Vaccine (English version)
SKU: SM345

Schulman, Kevin; Thiagaraj, Abishek

Product #:SM345

Supplier:Stanford University

Discipline:Strategy

Setting:Botswana;United States

Details:Case (PDF) • 23 pages • 2021-04-27

Subjects:

Innovation Public-private partnerships Government and business Strategy

Geography:

Botswana United States Africa North America

Your Price:

$11.64

Purchase this material with a free Educator Account and enjoy more benefits:

Free Educator Copy
Free Teaching Notes
Build your coursepack
Discounted academic price

As the COVID-19 pandemic shut down businesses and schools in 2020, global health authorities and governments kick-started the quest for a vaccine for the novel coronavirus. This case study details Operation Warp Speed, the $18 billion public-private partnership initiated by the U.S. government to accelerate the research, development, manufacture and distribution of COVID-19 vaccine therapies. The case explores the history of public-private partnerships in the United States, and the ambitious U.S. government effort to deliver 300 million doses of a COVID-19 vaccine by January 2021.

Learning Objectives

The case study is designed to help students explore the theory, economics, and risks of public-private partnerships-and specifically how to gauge the success of Operation Warp Speed, which aimed to develop and supply COVID-19 vaccine therapies in large quantities to vaccinate the U.S. population.